Annual Shareholders Equity
$21.19 M
-$12.10 M-36.36%
December 31, 2023
Summary
- As of February 8, 2025, RGLS annual stockholders equity is $21.19 million, with the most recent change of -$12.10 million (-36.36%) on December 31, 2023.
- During the last 3 years, RGLS annual shareholders equity has fallen by -$4.84 million (-18.59%).
- RGLS annual shareholders equity is now -83.95% below its all-time high of $132.01 million, reached on December 31, 2014.
Performance
RGLS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$86.81 M
-$11.38 M-11.59%
September 30, 2024
Summary
- As of February 8, 2025, RGLS quarterly stockholders equity is $86.81 million, with the most recent change of -$11.38 million (-11.59%) on September 30, 2024.
- Over the past year, RGLS quarterly shareholders equity has dropped by -$11.38 million (-11.59%).
- RGLS quarterly shareholders equity is now -40.88% below its all-time high of $146.82 million, reached on March 31, 2015.
Performance
RGLS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
RGLS Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.4% | -11.6% |
| 3 y3 years | -18.6% | +104.9% |
| 5 y5 years | +461.9% | +10000.0% |
RGLS Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.5% | at low | -19.3% | +309.7% |
| 5 y | 5-year | -61.5% | +5.9% | -19.3% | +1019.5% |
| alltime | all time | -84.0% | +151.1% | -40.9% | +269.7% |
Regulus Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $86.81 M(-11.6%) |
| Jun 2024 | - | $98.18 M(-8.7%) |
| Mar 2024 | - | $107.59 M(+407.8%) |
| Dec 2023 | $21.19 M(-36.4%) | $21.19 M(-25.0%) |
| Sep 2023 | - | $28.26 M(-16.9%) |
| Jun 2023 | - | $34.00 M(+27.8%) |
| Mar 2023 | - | $26.59 M(-20.1%) |
| Dec 2022 | $33.29 M(-39.4%) | $33.29 M(-16.1%) |
| Sep 2022 | - | $39.67 M(-6.4%) |
| Jun 2022 | - | $42.37 M(-14.0%) |
| Mar 2022 | - | $49.24 M(-10.4%) |
| Dec 2021 | $54.96 M(+111.2%) | $54.96 M(+89.4%) |
| Sep 2021 | - | $29.01 M(-21.2%) |
| Jun 2021 | - | $36.83 M(+35.8%) |
| Mar 2021 | - | $27.11 M(+4.2%) |
| Dec 2020 | $26.03 M(+30.0%) | $26.03 M(+235.6%) |
| Sep 2020 | - | $7.75 M(-9.7%) |
| Jun 2020 | - | $8.58 M(-42.4%) |
| Mar 2020 | - | $14.90 M(-25.5%) |
| Dec 2019 | $20.02 M(-441.9%) | $20.02 M(<-9900.0%) |
| Sep 2019 | - | -$143.00 K(-103.0%) |
| Jun 2019 | - | $4.74 M(-178.2%) |
| Mar 2019 | - | -$6.07 M(+3.7%) |
| Dec 2018 | -$5.85 M | -$5.85 M(-471.0%) |
| Sep 2018 | - | $1.58 M(-84.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $10.43 M(-54.4%) |
| Mar 2018 | - | $22.88 M(-35.0%) |
| Dec 2017 | $35.22 M(-37.2%) | $35.22 M(-27.5%) |
| Sep 2017 | - | $48.58 M(+143.0%) |
| Jun 2017 | - | $20.00 M(-48.4%) |
| Mar 2017 | - | $38.73 M(-30.9%) |
| Dec 2016 | $56.08 M(-54.8%) | $56.08 M(-22.9%) |
| Sep 2016 | - | $72.69 M(-17.8%) |
| Jun 2016 | - | $88.45 M(-17.5%) |
| Mar 2016 | - | $107.23 M(-13.6%) |
| Dec 2015 | $124.08 M(-6.0%) | $124.08 M(-1.4%) |
| Sep 2015 | - | $125.86 M(-5.1%) |
| Jun 2015 | - | $132.63 M(-9.7%) |
| Mar 2015 | - | $146.82 M(+11.2%) |
| Dec 2014 | $132.01 M(+41.3%) | $132.01 M(+78.2%) |
| Sep 2014 | - | $74.08 M(-9.7%) |
| Jun 2014 | - | $82.08 M(-11.1%) |
| Mar 2014 | - | $92.29 M(-1.3%) |
| Dec 2013 | $93.46 M(+50.5%) | $93.46 M(-1.0%) |
| Sep 2013 | - | $94.45 M(+91.5%) |
| Jun 2013 | - | $49.32 M(-11.7%) |
| Mar 2013 | - | $55.87 M(-10.0%) |
| Dec 2012 | $62.09 M(-249.6%) | $62.09 M(-221.4%) |
| Sep 2012 | - | -$51.15 M(-2159.1%) |
| Jun 2012 | - | $2.48 M(-106.0%) |
| Dec 2011 | -$41.49 M | -$41.49 M |
FAQ
- What is Regulus Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Regulus Therapeutics?
- What is Regulus Therapeutics annual shareholders equity year-on-year change?
- What is Regulus Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Regulus Therapeutics?
- What is Regulus Therapeutics quarterly shareholders equity year-on-year change?
What is Regulus Therapeutics annual stockholders equity?
The current annual shareholders equity of RGLS is $21.19 M
What is the all time high annual shareholders equity for Regulus Therapeutics?
Regulus Therapeutics all-time high annual stockholders equity is $132.01 M
What is Regulus Therapeutics annual shareholders equity year-on-year change?
Over the past year, RGLS annual stockholders equity has changed by -$12.10 M (-36.36%)
What is Regulus Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of RGLS is $86.81 M
What is the all time high quarterly shareholders equity for Regulus Therapeutics?
Regulus Therapeutics all-time high quarterly stockholders equity is $146.82 M
What is Regulus Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, RGLS quarterly stockholders equity has changed by -$11.38 M (-11.59%)